Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The study also aims to determine the effect of a strong enzyme (CYP3A4) inducer-rifampin- on
drug exposure of Glasdegib. This study will be conducted in healthy subjects given a single
dose of glasdegib in each period.